XML 27 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash Flows from Operating Activities:        
Net loss $ (168,748) $ (326,717) $ (1,285,773) $ (1,337,377)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation and amortization 8,584 9,734 38,733 29,790
Net realized (gains) losses on the sale of securities (192,405) (10,838) (100,378) 1,524
Amortization of investment securities, net 8,789 5,520 22,014 18,596
Deferred acquisition costs capitalized (70,818) (48,382) (221,410) (146,539)
Deferred acquisition costs amortized 37,764 37,457 153,671 113,294
Interest credited on deposit type contracts 16,597 14,244 80,452 31,478
(Increase) decrease in operating assets:        
Investment income due and accrued 6,255 10,909 (22,173) (36,251)
Reinsurance related assets (207) 3,484 (9,946) (14,148)
Pre-paid expenses (4,277) 32,202 119,688 (85,512)
Other assets (18,225) 2,003 (40,944) 5,607
Increase (decrease) in operating liabilities:        
Policyowner benefit reserves 389,568 390,000 1,643,251 1,245,220
Advance premiums 11,247 15,740 52,371 39,041
Other liabilities 14,352 12,037 (787) 3,674
Accounts payable and accrued expenses 2,796 (24,110) (19,416) 46,876
Net cash provided by (used in) operating activities 41,272 123,283 409,353 (84,727)
Cash Flows from Investing Activities:        
Purchase of fixed income investments (1,479,152) (269,208) (3,028,015) (3,173,315)
Purchase of equity investments (180,567) (395,268) (1,955,888) (1,814,947)
Proceeds from fixed income sales and repayments 154,696 153,393 1,003,308 783,123
Proceeds from equity sales and repayments 92,247 670,706 452,940
Net cash (used in) investing activities (1,505,023) (418,836) (3,309,889) (3,815,607)
Cash Flows from Financing Activities:        
Receipts on deposit-type contracts 579,215 441,382 1,989,833 910,817
Withdrawals on deposit-type contracts (137,761) (74,577) (246,103) (54,623)
Proceeds received from exercise of warrants, net of costs of issuance 54,212 1,881,819 1,836,025 4,935,661
Net cash provided by financing activities 495,666 2,248,624 3,579,755 5,791,855
Net increase in cash and cash equivalents (968,085) 1,953,071 679,219 1,891,521
Cash and Cash Equivalents:        
Beginning 3,145,745 2,466,526 2,466,526 575,005
Ending $ 2,177,660 $ 4,419,597 $ 3,145,745 $ 2,466,526